Fed. Circ. Upholds PTAB Ax Of 7 Xyrem Patents
The Federal Circuit maintained a win on Friday for generic-drug maker Amneal Pharmaceuticals LLC, affirming multiple inter partes reviews that invalidated claims in seven patents related to a narcolepsy drug called...To view the full article, register now.
Already a subscriber? Click here to view full article